{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:04:13Z","timestamp":1773450253213,"version":"3.50.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["SAF2013-48754-C2-1-R"],"award-info":[{"award-number":["SAF2013-48754-C2-1-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["SAF2016-79607R"],"award-info":[{"award-number":["SAF2016-79607R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["B2017\/BMD-3731"],"award-info":[{"award-number":["B2017\/BMD-3731"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["co-financed"],"award-info":[{"award-number":["co-financed"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["co-financed"],"award-info":[{"award-number":["co-financed"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ayuda para contrato predoctoral para la formaci\u00f3n de doctores from Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","award":["BES-2014-068148"],"award-info":[{"award-number":["BES-2014-068148"]}]},{"name":"Ayuda para la contrataci\u00f3n de investigadores predoctorales from Consejer\u00eda de Educaci\u00f3n, Juventud y Deporte, Comunidad de Madrid","award":["PEJD-2017-PRE\/BMD-4692"],"award-info":[{"award-number":["PEJD-2017-PRE\/BMD-4692"]}]},{"name":"Youth Employment Initiative","award":["co-financed"],"award-info":[{"award-number":["co-financed"]}]},{"name":"Contrato predoctoral para la formaci\u00f3n de profesorado universitario from Ministerio de Ciencia, Innovaci\u00f3n y Universidades","award":["FPU17\/01914"],"award-info":[{"award-number":["FPU17\/01914"]}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","award":["Institutional grant"],"award-info":[{"award-number":["Institutional grant"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010784","name":"Banco de Santander","doi-asserted-by":"crossref","award":["Institutional grant"],"award-info":[{"award-number":["Institutional grant"]}],"id":[{"id":"10.13039\/100010784","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1007\/s00430-019-00597-7","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T09:10:20Z","timestamp":1553159420000},"page":"349-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Vaccine vectors: the bright side of cytomegalovirus"],"prefix":"10.1007","volume":"208","author":[{"given":"Andrea C.","family":"M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rodr\u00edguez-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-4279","authenticated-orcid":false,"given":"Margarita","family":"Del Val","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"597_CR1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1462-5822.2011.01594.x","volume":"13","author":"NS Butler","year":"2011","unstructured":"Butler NS, Nolz JC, Harty JT (2011) Immunologic considerations for generating memory CD8 T cells through vaccination. Cell Microbiol 13:925\u2013933","journal-title":"Cell Microbiol"},{"key":"597_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.21.120601.141045","volume":"21","author":"RM Zinkernagel","year":"2003","unstructured":"Zinkernagel RM (2003) On natural and artificial vaccinations. Annu Rev Immunol 21:515\u2013546","journal-title":"Annu Rev Immunol"},{"key":"597_CR3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","volume":"202","author":"AW Sylwester","year":"2005","unstructured":"Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, Nelson JA, Picker LJ (2005) Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects. J Exp Med 202:673\u2013685","journal-title":"J Exp Med"},{"key":"597_CR4","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.4049\/jimmunol.170.4.2022","volume":"170","author":"U Karrer","year":"2003","unstructured":"Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, Phillips RE, Klenerman P (2003) Memory inflation: continuous accumulation of antiviral CD8 + T cells over time. J Immunol 170:2022\u20132029 [Correction appeared in J. Immunol. 171, 3895 (2003)]","journal-title":"J Immunol"},{"key":"597_CR5","first-page":"450","volume-title":"Cytomegaloviruses: from molecular pathogenesis to intervention, Chap. 21","author":"MA Jarvis","year":"2013","unstructured":"Jarvis MA, Hansen SG, Nelson JA, Picker LJ, Fruh K (2013) Vaccine vectors using the unique biology and immunology of cytomegalovirus. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, Chap. 21, vol\u00a0II. Caister Academic Press, Norfolk, pp\u00a0450\u2013463"},{"key":"597_CR6","doi-asserted-by":"crossref","first-page":"11495","DOI":"10.1128\/JVI.74.24.11495-11503.2000","volume":"74","author":"R Holtappels","year":"2000","unstructured":"Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ (2000) Enrichment of immediate-early 1 (m123\/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74:11495\u201311503","journal-title":"J Virol"},{"key":"597_CR7","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1128\/JVI.78.5.2255-2264.2004","volume":"78","author":"U Karrer","year":"2004","unstructured":"Karrer U, Wagner M, Sierro S, Oxenius A, Hengel H, Dumrese T, Freigang S, Koszinowski UH, Phillips RE, Klenerman P (2004) Expansion of protective CD8 + T-cell responses driven by recombinant cytomegaloviruses. J Virol 78:2255\u20132264","journal-title":"J Virol"},{"key":"597_CR8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/eji.200425534","volume":"35","author":"S Sierro","year":"2005","unstructured":"Sierro S, Rothkopf R, Klenerman P (2005) Evolution of diverse antiviral CD8 + T cell populations after murine cytomegalovirus infection. Eur J Immunol 35:1113\u20131123","journal-title":"Eur J Immunol"},{"key":"597_CR9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.177.1.450","volume":"177","author":"MW Munks","year":"2006","unstructured":"Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB (2006) Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 177:450\u2013458","journal-title":"J Immunol"},{"key":"597_CR10","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1128\/JVI.74.16.7496-7507.2000","volume":"74","author":"J Podlech","year":"2000","unstructured":"Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74:7496\u20137507","journal-title":"J Virol"},{"key":"597_CR11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.immuni.2008.07.017","volume":"29","author":"CM Snyder","year":"2008","unstructured":"Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB (2008) Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29:650\u2013659","journal-title":"Immunity"},{"key":"597_CR12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4049\/jimmunol.177.2.831","volume":"177","author":"D Masopust","year":"2006","unstructured":"Masopust D, Ha SJ, Vezys V, Ahmed R (2006) Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol 177:831\u2013839","journal-title":"J Immunol"},{"key":"597_CR13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745\u2013763","journal-title":"Annu Rev Immunol"},{"key":"597_CR14","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1128\/JVI.03177-15","volume":"90","author":"SPM Welten","year":"2016","unstructured":"Welten SPM, Redeker A, Toes REM, Arens R (2016) Viral persistence induces antibody inflation without altering antibody avidity. J Virol 90:4402\u20134411","journal-title":"J Virol"},{"key":"597_CR15","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1016\/j.vaccine.2009.01.055","volume":"27","author":"F Lemiale","year":"2009","unstructured":"Lemiale F, Korokhov N (2009) Lentiviral vectors for HIV disease prevention and treatment. Vaccine 27:3443\u20133449","journal-title":"Vaccine"},{"key":"597_CR16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-med-042010-085643","volume":"63","author":"LJ Picker","year":"2012","unstructured":"Picker LJ, Hansen SG, Lifson JD (2012) New paradigms for HIV\/AIDS vaccine development. Annu Rev Med 63:95\u2013111","journal-title":"Annu Rev Med"},{"key":"597_CR17","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.4049\/jimmunol.1202665","volume":"190","author":"B Bolinger","year":"2013","unstructured":"Bolinger B, Sims S, O\u2019Hara G, de Lara C, Tchilian E, Firner S, Engeler D, Ludewig B, Klenerman P (2013) A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector. J Immunol 190:4162\u20134174","journal-title":"J Immunol"},{"key":"597_CR18","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.4049\/jimmunol.1502687","volume":"196","author":"JM Colston","year":"2016","unstructured":"Colston JM, Bolinger B, Cottingham MG, Gilbert S, Klenerman P (2016) Modification of antigen impacts on memory quality after adenovirus vaccination. J Immunol 196:3354\u20133363","journal-title":"J Immunol"},{"key":"597_CR19","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1073\/pnas.91.19.8802","volume":"91","author":"AJ Bett","year":"1994","unstructured":"Bett AJ, Haddara W, Prevec L, Graham FL (1994) An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A 91:8802\u20138806","journal-title":"Proc Natl Acad Sci U S A"},{"key":"597_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"A Kenneson","year":"2007","unstructured":"Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253\u2013276","journal-title":"Rev Med Virol"},{"key":"597_CR21","doi-asserted-by":"crossref","first-page":"e1002295","DOI":"10.1371\/journal.ppat.1002295","volume":"7","author":"CM Snyder","year":"2011","unstructured":"Snyder CM, Cho KS, Bonnett EL, Allan JE, Hill AB (2011) Sustained CD8 + T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog 7:e1002295","journal-title":"PLoS Pathog"},{"key":"597_CR22","first-page":"362ra145","volume":"8","author":"D Wang","year":"2016","unstructured":"Wang D, Freed DC, He X, Li F, Tang A, Cox KS, Dubey SA, Cole S, Medi MB, Liu Y, Xu J, Zhang ZQ, Finnefrock AC, Song L, Espeseth AS, Shiver JW, Casimiro DR, Fu TM (2016) A replication-defective human cytomegalovirus vaccine for prevention of congenital infection. Sci Transl Med 8:362ra145","journal-title":"Sci Transl Med"},{"key":"597_CR23","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1128\/JVI.01911-07","volume":"81","author":"L Cicin-Sain","year":"2007","unstructured":"Cicin-Sain L, Bubic I, Schnee M, Ruzsics Z, Mohr C, Jonjic S, Koszinowski UH (2007) Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. J Virol 81:13825\u201313834","journal-title":"J Virol"},{"key":"597_CR24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.mib.2010.05.011","volume":"13","author":"VJ Lisnic","year":"2010","unstructured":"Lisnic VJ, Krmpotic A, Jonjic S (2010) Modulation of natural killer cell activity by viruses. Curr Opin Microbiol 13:530\u2013539","journal-title":"Curr Opin Microbiol"},{"key":"597_CR25","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1172\/JCI43961","volume":"120","author":"I Slavuljica","year":"2010","unstructured":"Slavuljica I, Busche A, Babic M, Mitrovic M, Gasparovic I, Cekinovic D, Markova Car E, Pernjak Pugel E, Cikovic A, Lisnic VJ, Britt WJ, Koszinowski U, Messerle M, Krmpotic A, Jonjic S (2010) Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest 120:4532\u20134545","journal-title":"J Clin Invest"},{"key":"597_CR26","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.175.5.2825","volume":"175","author":"MA Markiewicz","year":"2005","unstructured":"Markiewicz MA, Carayannopoulos LN, Naidenko OV, Matsui K, Burack WR, Wise EL, Fremont DH, Allen PM, Yokoyama WM, Colonna M, Shaw AS (2005) Costimulation through NKG2D enhances murine CD8 + CTL function: similarities and differences between NKG2D and CD28 costimulation. J Immunol 175:2825\u20132833","journal-title":"J Immunol"},{"key":"597_CR27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1084\/jem.176.3.729","volume":"176","author":"M Del Val","year":"1992","unstructured":"Del Val M, Hengel H, Hacker H, Hartlaub U, Ruppert T, Lucin P, Koszinowski UH (1992) Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med 176:729\u2013738","journal-title":"J Exp Med"},{"key":"597_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1074-7613(00)80242-3","volume":"6","author":"H Ziegler","year":"1997","unstructured":"Ziegler H, Th\u00e4le R, Lucin P, Muranyi W, Flohr T, Hengel H, Farrell H, Rawlinson W, Koszinowski UH (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC\/cis-Golgi compartments. Immunity 6:57\u201366","journal-title":"Immunity"},{"key":"597_CR29","doi-asserted-by":"crossref","first-page":"11637","DOI":"10.1128\/JVI.01510-08","volume":"82","author":"V Bohm","year":"2008","unstructured":"Bohm V, Simon CO, Podlech J, Seckert CK, Gendig D, Deegen P, Gillert-Marien D, Lemmermann NA, Holtappels R, Reddehase MJ (2008) The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation. J Virol 82:11637\u201311650","journal-title":"J Virol"},{"key":"597_CR30","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/jvi.65.7.3641-3646.1991","volume":"65","author":"M Del Val","year":"1991","unstructured":"Del Val M, Schlicht HJ, Volkmer H, Messerle M, Reddehase MJ, Koszinowski UH (1991) Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J Virol 65:3641\u20133646","journal-title":"J Virol"},{"key":"597_CR31","doi-asserted-by":"crossref","first-page":"16550","DOI":"10.1073\/pnas.1310215110","volume":"110","author":"T Trsan","year":"2013","unstructured":"Trsan T, Busche A, Abram M, Wensveen FM, Lemmermann NA, Arapovic M, Babic M, Tomic A, Golemac M, Brinkmann MM, Jager W, Oxenius A, Polic B, Krmpotic A, Messerle M, Jonjic S (2013) Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1gamma. Proc Natl Acad Sci USA 110:16550\u201316555","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR32","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/eji.201746964","volume":"47","author":"T Trsan","year":"2017","unstructured":"Trsan T, Vukovic K, Filipovic P, Brizic AL, Lemmermann NAW, Schober K, Busch DH, Britt WJ, Messerle M, Krmpotic A, Jonjic S (2017) Cytomegalovirus vector expressing RAE-1gamma induces enhanced anti-tumor capacity of murine CD8+ T cells. Eur J Immunol 47:1354\u20131367","journal-title":"Eur J Immunol"},{"key":"597_CR33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fimmu.2018.00991","volume":"9","author":"L Hirsl","year":"2018","unstructured":"Hirsl L, Brizic I, Jenus T, Juranic Lisnic V, Reichel JJ, Jurkovic S, Krmpotic A, Jonjic S (2018) Murine CMV expressing the high affinity NKG2D ligand MULT-1: a model for the development of cytomegalovirus-based vaccines. Front Immunol 9:991","journal-title":"Front Immunol"},{"key":"597_CR34","doi-asserted-by":"crossref","first-page":"12203","DOI":"10.1128\/JVI.77.22.12203-12210.2003","volume":"77","author":"AA Rizvanov","year":"2003","unstructured":"Rizvanov AA, van Geelen AG, Morzunov S, Otteson EW, Bohlman C, Pari GS, St Jeor SC (2003) Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein. J Virol 77:12203\u201312210","journal-title":"J Virol"},{"key":"597_CR35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2005.07.070","volume":"24","author":"AA Rizvanov","year":"2006","unstructured":"Rizvanov AA, Khaiboullina SF, van Geelen AG, St Jeor SC (2006) Replication and immunoactivity of the recombinant Peromyscus maniculatus cytomegalovirus expressing hantavirus G1 glycoprotein in vivo and in vitro. Vaccine 24:327\u2013334","journal-title":"Vaccine"},{"key":"597_CR36","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1016\/j.vaccine.2013.07.025","volume":"31","author":"JW Hooper","year":"2013","unstructured":"Hooper JW, Josleyn M, Ballantyne J, Brocato R (2013) A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Vaccine 31:4314\u20134321","journal-title":"Vaccine"},{"key":"597_CR37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1152622","volume":"320","author":"BD Walker","year":"2008","unstructured":"Walker BD, Burton DR (2008) Toward an AIDS vaccine. Science 320:760\u2013764","journal-title":"Science"},{"key":"597_CR38","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","volume":"372","author":"SP Buchbinder","year":"2008","unstructured":"Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881\u20131893","journal-title":"Lancet"},{"key":"597_CR39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jis342","volume":"206","author":"A Duerr","year":"2012","unstructured":"Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN (2012) Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (step study). J Infect Dis 206:258\u2013266","journal-title":"J Infect Dis"},{"key":"597_CR40","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1016\/j.vaccine.2011.08.098","volume":"29","author":"F Garcia","year":"2011","unstructured":"Garcia F, Bernaldo de Quiros JC, Gomez CE, Perdiguero B, Najera JL, Jimenez V, Garcia-Arriaza J, Guardo AC, Perez I, Diaz-Brito V, Conde MS, Gonzalez N, Alvarez A, Alcami J, Jimenez JL, Pich J, Arnaiz JA, Maleno MJ, Leon A, Munoz-Fernandez MA, Liljestrom P, Weber J, Pantaleo G, Gatell JM, Plana M, Esteban M (2011) Safety and immunogenicity of a modified pox vector-based HIV\/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: a phase I clinical trial (RISVAC02). Vaccine 29:8309\u20138316","journal-title":"Vaccine"},{"key":"597_CR41","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1128\/JVI.05165-11","volume":"85","author":"CE Gomez","year":"2011","unstructured":"Gomez CE, Najera JL, Perdiguero B, Garcia-Arriaza J, Sorzano CO, Jimenez V, Gonzalez-Sanz R, Jimenez JL, Munoz-Fernandez MA, Lopez Bernaldo de Quiros JC, Guardo AC, Garcia F, Gatell JM, Plana M, Esteban M (2011) The HIV\/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens. J Virol 85:11468\u201311478","journal-title":"J Virol"},{"key":"597_CR42","doi-asserted-by":"crossref","first-page":"e0186602","DOI":"10.1371\/journal.pone.0186602","volume":"12","author":"AC Guardo","year":"2017","unstructured":"Guardo AC, Gomez CE, Diaz-Brito V, Pich J, Arnaiz JA, Perdiguero B, Garcia-Arriaza J, Gonzalez N, Sorzano COS, Jimenez L, Jimenez JL, Munoz-Fernandez MA, Gatell JM, Alcami J, Esteban M, de Quiros JC, Garcia F, Plana M (2017) Lopez Bernaldo. Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4\u00a0years after the last immunization. PLoS One 12:e0186602","journal-title":"PLoS One"},{"key":"597_CR43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nm.1935","volume":"15","author":"SG Hansen","year":"2009","unstructured":"Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, Drummond DD, Legasse AW, Axthelm MK, Oswald K, Trubey CM, Piatak M Jr, Lifson JD, Nelson JA, Jarvis MA, Picker LJ (2009) Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15:293\u2013299","journal-title":"Nat Med"},{"key":"597_CR44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","volume":"473","author":"SG Hansen","year":"2011","unstructured":"Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, Coyne-Johnson L, Whizin N, Oswald K, Shoemaker R, Swanson T, Legasse AW, Chiuchiolo MJ, Parks CL, Axthelm MK, Nelson JA, Jarvis MA, Piatak M Jr, Lifson JD, Picker LJ (2011) Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473:523\u2013527","journal-title":"Nature"},{"key":"597_CR45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","volume":"502","author":"SG Hansen","year":"2013","unstructured":"Hansen SG, Piatak M Jr, Ventura AB, Hughes CM, Gilbride RM, Ford JC, Oswald K, Shoemaker R, Li Y, Lewis MS, Gilliam AN, Xu G, Whizin N, Burwitz BJ, Planer SL, Turner JM, Legasse AW, Axthelm MK, Nelson JA, Fruh K, Sacha JB, Estes JD, Keele BF, Edlefsen PT, Lifson JD, Picker LJ (2013) Immune clearance of highly pathogenic SIV infection. Nature 502:100\u2013104","journal-title":"Nature"},{"key":"597_CR46","doi-asserted-by":"crossref","first-page":"1237874","DOI":"10.1126\/science.1237874","volume":"340","author":"SG Hansen","year":"2013","unstructured":"Hansen SG, Sacha JB, Hughes CM, Ford JC, Burwitz BJ, Scholz I, Gilbride RM, Lewis MS, Gilliam AN, Ventura AB, Malouli D, Xu G, Richards R, Whizin N, Reed JS, Hammond KB, Fischer M, Turner JM, Legasse AW, Axthelm MK, Edlefsen PT, Nelson JA, Lifson JD, Fruh K, Picker LJ (2013) Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 340:1237874","journal-title":"Science"},{"key":"597_CR47","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.aac9475","volume":"351","author":"SG Hansen","year":"2016","unstructured":"Hansen SG, Wu HL, Burwitz BJ, Hughes CM, Hammond KB, Ventura AB, Reed JS, Gilbride RM, Ainslie E, Morrow DW, Ford JC, Selseth AN, Pathak R, Malouli D, Legasse AW, Axthelm MK, Nelson JA, Gillespie GM, Walters LC, Brackenridge S, Sharpe HR, Lopez CA, Fruh K, Korber BT, McMichael AJ, Gnanakaran S, Sacha JB, Picker LJ (2016) Broadly targeted CD8(+) T cell responses restricted by major histocompatibility complex E. Science 351:714\u2013720","journal-title":"Science"},{"key":"597_CR48","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s11262-017-1452-0","volume":"53","author":"NM Suarez","year":"2017","unstructured":"Suarez NM, Lau B, Kemble GM, Lee R, Mocarski ES, Wilkinson GWG, Adler SP, McVoy MA, Davison AJ (2017) Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo. Virus Genes 53:650\u2013655","journal-title":"Virus Genes"},{"key":"597_CR49","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1084\/jem.20161988","volume":"214","author":"SE Murray","year":"2017","unstructured":"Murray SE, Nesterenko PA, Vanarsdall AL, Munks MW, Smart SM, Veziroglu EM, Sagario LC, Lee R, Claas FHJ, Doxiadis IIN, McVoy MA, Adler SP, Hill AB (2017) Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans. J Exp Med 214:1889\u20131899","journal-title":"J Exp Med"},{"key":"597_CR50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2017.06.010","volume":"47","author":"K Fruh","year":"2017","unstructured":"Fruh K, Picker L (2017) CD8 + T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination. Curr Opin Immunol 47:52\u201356","journal-title":"Curr Opin Immunol"},{"key":"597_CR51","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/503365","volume":"193","author":"TC Heineman","year":"2006","unstructured":"Heineman TC, Schleiss M, Bernstein DI, Spaete RR, Yan L, Duke G, Prichard M, Wang Z, Yan Q, Sharp MA, Klein N, Arvin AM, Kemble G (2006) A phase 1 study of 4 live, recombinant human cytomegalovirus Towne\/Toledo chimeric vaccines. J Infect Dis 193:1350\u20131360","journal-title":"J Infect Dis"},{"key":"597_CR52","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/infdis\/jiw365","volume":"214","author":"SP Adler","year":"2016","unstructured":"Adler SP, Manganello AM, Lee R, McVoy MA, Nixon DE, Plotkin S, Mocarski E, Cox JH, Fast PE, Nesterenko PA, Murray SE, Hill AB, Kemble G (2016) A phase 1 study of 4 live, recombinant human cytomegalovirus Towne\/Toledo chimera vaccines in cytomegalovirus-seronegative men. J Infect Dis 214:1341\u20131348","journal-title":"J Infect Dis"},{"key":"597_CR53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Konde MK, Keita S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Rottingen JA, Kieny MP (2017) Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet 389:505\u2013518","journal-title":"Lancet"},{"key":"597_CR54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","volume":"376","author":"JA Regules","year":"2017","unstructured":"Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Hu Z, Munoz P, Moon JE, Ruck RC, Bennett JW, Twomey PS, Gutierrez RL, Remich SA, Hack HR, Wisniewski ML, Josleyn MD, Kwilas SA, Van Deusen N, Mbaya OT, Zhou Y, Stanley DA, Jing W, Smith KS, Shi M, Ledgerwood JE, Graham BS, Sullivan NJ, Jagodzinski LL, Peel SA, Alimonti JB, Hooper JW, Silvera PM, Martin BK, Monath TP, Ramsey WJ, Link CJ, Lane HC, Michael NL, Davey RT Jr, Thomas SJ (2017) A recombinant vesicular stomatitis virus ebola vaccine. N Engl J Med 376:330\u2013341","journal-title":"N Engl J Med"},{"key":"597_CR55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","author":"SM Jones","year":"2005","unstructured":"Jones SM, Feldmann H, Stroher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, Daddario KM, Hensley LE, Jahrling PB, Geisbert TW (2005) Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11:786\u2013790","journal-title":"Nat Med"},{"key":"597_CR56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/14760584.2014.885841","volume":"13","author":"A Marzi","year":"2014","unstructured":"Marzi A, Feldmann H (2014) Ebola virus vaccines: an overview of current approaches. Expert Rev Vaccines 13:521\u2013531","journal-title":"Expert Rev Vaccines"},{"key":"597_CR57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","volume":"389","author":"FC Zhu","year":"2017","unstructured":"Zhu FC, Wurie AH, Hou LH, Liang Q, Li YH, Russell JB, Wu SP, Li JX, Hu YM, Guo Q, Xu WB, Wurie AR, Wang WJ, Zhang Z, Yin WJ, Ghazzawi M, Zhang X, Duan L, Wang JZ, Chen W (2017) Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 389:621\u2013628","journal-title":"Lancet"},{"key":"597_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy639","author":"N Venkatraman","year":"2018","unstructured":"Venkatraman N, Ndiaye BP, Bowyer G, Wade D, Sridhar S, Wright D, Powlson J, Ndiaye I, Dieye S, Thompson C, Bakhoum M, Morter R, Capone S, Sorbo MD, Jamieson S, Rampling T, Datoo M, Roberts R, Poulton I, Griffiths O, Ballou WR, Roman F, Lewis DJM, Lawrie A, Imoukhuede E, Gilbert SC, Dieye TN, Ewer KJ, Mboup S, Hill AVS (2018) Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen-ChAd3-EBO-Z followed by MVA-EBO-Z in healthy adults in the UK and Senegal. J Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/jiy639","journal-title":"J Infect Dis"},{"key":"597_CR59","doi-asserted-by":"crossref","first-page":"e00363","DOI":"10.1128\/JVI.00363-18","volume":"92","author":"A Lazaro-Frias","year":"2018","unstructured":"Lazaro-Frias A, Gomez-Medina S, Sanchez-Sampedro L, Ljungberg K, Ustav M, Liljestrom P, Munoz-Fontela C, Esteban M, Garcia-Arriaza J (2018) Distinct immunogenicity and efficacy of poxvirus-based vaccine candidates against Ebola Virus expressing GP and VP40 proteins. J Virol 92:e00363\u2013e00318","journal-title":"J Virol"},{"key":"597_CR60","doi-asserted-by":"crossref","first-page":"e1275","DOI":"10.1371\/journal.pntd.0001275","volume":"5","author":"Y Tsuda","year":"2011","unstructured":"Tsuda Y, Caposio P, Parkins CJ, Botto S, Messaoudi I, Cicin-Sain L, Feldmann H, Jarvis MA (2011) A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus. PLoS Negl Trop Dis 5:e1275","journal-title":"PLoS Negl Trop Dis"},{"key":"597_CR61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1092528","volume":"303","author":"EM Leroy","year":"2004","unstructured":"Leroy EM, Rouquet P, Formenty P, Souquiere S, Kilbourne A, Froment JM, Bermejo M, Smit S, Karesh W, Swanepoel R, Zaki SR, Rollin PE (2004) Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303:387\u2013390","journal-title":"Science"},{"key":"597_CR62","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.vaccine.2015.03.029","volume":"33","author":"Y Tsuda","year":"2015","unstructured":"Tsuda Y, Parkins CJ, Caposio P, Feldmann F, Botto S, Ball S, Messaoudi I, Cicin-Sain L, Feldmann H, Jarvis MA (2015) A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose. Vaccine 33:2261\u20132266","journal-title":"Vaccine"},{"key":"597_CR63","doi-asserted-by":"crossref","first-page":"21674","DOI":"10.1038\/srep21674","volume":"6","author":"A Marzi","year":"2016","unstructured":"Marzi A, Murphy AA, Feldmann F, Parkins CJ, Haddock E, Hanley PW, Emery MJ, Engelmann F, Messaoudi I, Feldmann H, Jarvis MA (2016) Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection. Sci Rep 6:21674","journal-title":"Sci Rep"},{"key":"597_CR64","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.vaccine.2012.02.043","volume":"30","author":"R Tierney","year":"2012","unstructured":"Tierney R, Nakai T, Parkins CJ, Caposio P, Fairweather NF, Sesardic D, Jarvis MA (2012) A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice. Vaccine 30:3047\u20133052","journal-title":"Vaccine"},{"key":"597_CR65","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/ije\/dyv142","volume":"44","author":"R Kashangura","year":"2015","unstructured":"Kashangura R, Sena ES, Young T, Garner P (2015) Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review. Int J Epidemiol 44:1970\u20131981","journal-title":"Int J Epidemiol"},{"key":"597_CR66","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","volume":"381","author":"MD Tameris","year":"2013","unstructured":"Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, Mahomed H, McShane H (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381:1021\u20131028","journal-title":"Lancet"},{"key":"597_CR67","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","volume":"181","author":"EK Forbes","year":"2008","unstructured":"Forbes EK, Sander C, Ronan EO, McShane H, Hill AV, Beverley PC, Tchilian EZ (2008) Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 181:4955\u20134964","journal-title":"J Immunol"},{"key":"597_CR68","doi-asserted-by":"crossref","first-page":"e5856","DOI":"10.1371\/journal.pone.0005856","volume":"4","author":"Z Xing","year":"2009","unstructured":"Xing Z, McFarland CT, Sallenave JM, Izzo A, Wang J, McMurray DN (2009) Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis. PLoS One 4:e5856","journal-title":"PLoS One"},{"key":"597_CR69","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","volume":"32","author":"G Dean","year":"2014","unstructured":"Dean G, Whelan A, Clifford D, Salguero FJ, Xing Z, Gilbert S, McShane H, Hewinson RG, Vordermeier M, Villarreal-Ramos B (2014) Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines. Vaccine 32:1304\u20131310","journal-title":"Vaccine"},{"key":"597_CR70","doi-asserted-by":"crossref","first-page":"e0135009","DOI":"10.1371\/journal.pone.0135009","volume":"10","author":"M Jeyanathan","year":"2015","unstructured":"Jeyanathan M, Shao Z, Yu X, Harkness R, Jiang R, Li J, Xing Z, Zhu T (2015) AdHu5Ag85A respiratory mucosal boost immunization enhances protection against pulmonary tuberculosis in BCG-primed non-human primates. PLoS One 10:e0135009","journal-title":"PLoS One"},{"key":"597_CR71","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4049\/jimmunol.1302523","volume":"193","author":"PC Beverley","year":"2014","unstructured":"Beverley PC, Ruzsics Z, Hey A, Hutchings C, Boos S, Bolinger B, Marchi E, O\u2019Hara G, Klenerman P, Koszinowski UH, Tchilian EZ (2014) A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis. J Immunol 193:2306\u20132316","journal-title":"J Immunol"},{"key":"597_CR72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.4473","volume":"24","author":"SG Hansen","year":"2018","unstructured":"Hansen SG, Zak DE, Xu G, Ford JC, Marshall EE, Malouli D, Gilbride RM, Hughes CM, Ventura AB, Ainslie E, Randall KT, Selseth AN, Rundstrom P, Herlache L, Lewis MS, Park H, Planer SL, Turner JM, Fischer M, Armstrong C, Zweig RC, Valvo J, Braun JM, Shankar S, Lu L, Sylwester AW, Legasse AW, Messerle M, Jarvis MA, Amon LM, Aderem A, Alter G, Laddy DJ, Stone M, Bonavia A, Evans TG, Axthelm MK, Fruh K, Edlefsen PT, Picker LJ (2018) Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine. Nat Med 24:130\u2013143","journal-title":"Nat Med"},{"key":"597_CR73","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2009.416","volume":"29","author":"F Pages","year":"2010","unstructured":"Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH (2010) Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29:1093\u20131102","journal-title":"Oncogene"},{"key":"597_CR74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2013.07.002","volume":"39","author":"M Kalos","year":"2013","unstructured":"Kalos M, June CH (2013) Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. Immunity 39:49\u201360","journal-title":"Immunity"},{"key":"597_CR75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg SA, Restifo NP (2015) Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348:62\u201368","journal-title":"Science"},{"key":"597_CR76","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June CH, O\u2019Connor RS, Kawalekar OU, Ghassemi S, Milone MC (2018) CAR T cell immunotherapy for human cancer. Science 359:1361\u20131365","journal-title":"Science"},{"key":"597_CR77","first-page":"15","volume":"13","author":"N Vigneron","year":"2013","unstructured":"Vigneron N, Stroobant V, Van den Eynde BJ, van der Bruggen P (2013) Database of T cell-defined human tumor antigens: the 2013 update. Cancer Immun 13:15","journal-title":"Cancer Immun"},{"key":"597_CR78","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/CJI.0b013e3182585d50","volume":"35","author":"EN Klyushnenkova","year":"2012","unstructured":"Klyushnenkova EN, Kouiavskaia DV, Parkins CJ, Caposio P, Botto S, Alexander RB, Jarvis MA (2012) A cytomegalovirus-based vaccine expressing a single tumor-specific CD8 + T-cell epitope delays tumor growth in a murine model of prostate cancer. J Immunother 35:390\u2013399","journal-title":"J Immunother"},{"key":"597_CR79","first-page":"42","volume":"28","author":"SH Lee","year":"2001","unstructured":"Lee SH, Girard S, Macina D, Busa M, Zafer A, Belouchi A, Gros P, Vidal SM (2001) Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 28:42\u201355","journal-title":"Nat Genet"},{"key":"597_CR80","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1084\/jem.20021713","volume":"197","author":"SH Lee","year":"2003","unstructured":"Lee SH, Zafer A, de Repentigny Y, Kothary R, Tremblay ML, Gros P, Duplay P, Webb JR, Vidal SM (2003) Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med 197:515\u2013526","journal-title":"J Exp Med"},{"key":"597_CR81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2013.06.068","volume":"437","author":"G Xu","year":"2013","unstructured":"Xu G, Smith T, Grey F, Hill AB (2013) Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice. Biochem Biophys Res Commun 437:287\u2013291","journal-title":"Biochem Biophys Res Commun"},{"key":"597_CR82","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2326-6066.CIR-14-0044","volume":"3","author":"Z Qiu","year":"2015","unstructured":"Qiu Z, Huang H, Grenier JM, Perez OA, Smilowitz HM, Adler B, Khanna KM (2015) Cytomegalovirus-based vaccine expressing a modified tumor antigen induces potent tumor-specific CD8(+) T-cell response and protects mice from melanoma. Cancer Immunol Res 3:536\u2013546","journal-title":"Cancer Immunol Res"},{"key":"597_CR83","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3389\/fimmu.2017.01993","volume":"8","author":"JM Grenier","year":"2017","unstructured":"Grenier JM, Yeung ST, Qiu Z, Jellison ER, Khanna KM (2017) Combining adoptive cell therapy with cytomegalovirus-based vaccine is protective against solid skin tumors. Front Immunol 8:1993","journal-title":"Front Immunol"},{"key":"597_CR84","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/mt.2016.121","volume":"24","author":"DA Erkes","year":"2016","unstructured":"Erkes DA, Xu G, Daskalakis C, Zurbach KA, Wilski NA, Moghbeli T, Hill AB, Snyder CM (2016) Intratumoral infection with murine cytomegalovirus synergizes with PD-L1 blockade to clear melanoma lesions and induce long-term immunity. Mol Ther 24:1444\u20131455","journal-title":"Mol Ther"},{"key":"597_CR85","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1080\/21645515.2017.1331795","volume":"13","author":"DA Erkes","year":"2017","unstructured":"Erkes DA, Wilski NA, Snyder CM (2017) Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity. Hum Vaccin Immunother 13:1778\u20131785","journal-title":"Hum Vaccin Immunother"},{"key":"597_CR86","doi-asserted-by":"crossref","first-page":"e1006072","DOI":"10.1371\/journal.ppat.1006072","volume":"12","author":"I Dekhtiarenko","year":"2016","unstructured":"Dekhtiarenko I, Ratts RB, Blatnik R, Lee LN, Fischer S, Borkner L, Oduro JD, Marandu TF, Hoppe S, Ruzsics Z, Sonnemann JK, Mansouri M, Meyer C, Lemmermann NA, Holtappels R, Arens R, Klenerman P, Fruh K, Reddehase MJ, Riemer AB, Cicin-Sain L (2016) Peptide processing is critical for T-cell memory inflation and may be optimized to improve immune protection by CMV-based vaccine vectors. PLoS Pathog 12:e1006072","journal-title":"PLoS Pathog"},{"key":"597_CR87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40425-019-0500-9","volume":"7","author":"E Beyranvand Nejad","year":"2019","unstructured":"Beyranvand Nejad E, Ratts RB, Panagioti E, Meyer C, Oduro JD, Cicin-Sain L, Fruh K, van der Burg SH, Arens R (2019) Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection. J Immunother Cancer 7:25","journal-title":"J Immunother Cancer"},{"key":"597_CR88","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1099\/jgv.0.000339","volume":"97","author":"JD Oduro","year":"2016","unstructured":"Oduro JD, Redeker A, Lemmermann NA, Ebermann L, Marandu TF, Dekhtiarenko I, Holzki JK, Busch DH, Arens R, Cicin-Sain L (2016) Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection. J Gen Virol 97:185\u2013195","journal-title":"J Gen Virol"},{"key":"597_CR89","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/eji.201343946","volume":"44","author":"A Redeker","year":"2014","unstructured":"Redeker A, Welten SP, Arens R (2014) Viral inoculum dose impacts memory T-cell inflation. Eur J Immunol 44:1046\u20131057","journal-title":"Eur J Immunol"},{"key":"597_CR90","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.4049\/jimmunol.1203173","volume":"190","author":"I Dekhtiarenko","year":"2013","unstructured":"Dekhtiarenko I, Jarvis MA, Ruzsics Z, Cicin-Sain L (2013) The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigens. J Immunol 190:3399\u20133409","journal-title":"J Immunol"},{"key":"597_CR91","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(91)90037-Y","volume":"66","author":"M Del Val","year":"1991","unstructured":"Del Val M, Schlicht HJ, Ruppert T, Reddehase MJ, Koszinowski UH (1991) Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66:1145\u20131153","journal-title":"Cell"},{"key":"597_CR92","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4049\/jimmunol.1602115","volume":"199","author":"L Borkner","year":"2017","unstructured":"Borkner L, Sitnik KM, Dekhtiarenko I, Pulm AK, Tao R, Drexler I, Cicin-Sain L (2017) Immune protection by a cytomegalovirus vaccine vector expressing a single low-avidity epitope. J Immunol 199:1737\u20131747","journal-title":"J Immunol"},{"key":"597_CR93","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1002\/eji.201242606","volume":"42","author":"M Aleksic","year":"2012","unstructured":"Aleksic M, Liddy N, Molloy PE, Pumphrey N, Vuidepot A, Chang KM, Jakobsen BK (2012) Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies. Eur J Immunol 42:3174\u20133179","journal-title":"Eur J Immunol"},{"key":"597_CR94","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00430-012-0268-8","volume":"201","author":"S Ebert","year":"2012","unstructured":"Ebert S, Lemmermann NA, Thomas D, Renzaho A, Reddehase MJ, Holtappels R (2012) Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells. Med Microbiol Immunol 201:541\u2013550","journal-title":"Med Microbiol Immunol"},{"key":"597_CR95","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri.2015.3","volume":"16","author":"SN Mueller","year":"2016","unstructured":"Mueller SN, Mackay LK (2016) Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol 16:79\u201389","journal-title":"Nat Rev Immunol"},{"key":"597_CR96","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/mi.2016.48","volume":"10","author":"KM Morabito","year":"2017","unstructured":"Morabito KM, Ruckwardt TR, Redwood AJ, Moin SM, Price DA, Graham BS (2017) Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung. Mucosal Immunol 10:545\u2013554","journal-title":"Mucosal Immunol"},{"key":"597_CR97","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.celrep.2015.09.076","volume":"13","author":"CJ Smith","year":"2015","unstructured":"Smith CJ, Caldeira-Dantas S, Turula H, Snyder CM (2015) Murine CMV infection induces the continuous production of mucosal resident T cells. Cell Rep 13:1137\u20131148","journal-title":"Cell Rep"},{"key":"597_CR98","doi-asserted-by":"crossref","first-page":"e1006993","DOI":"10.1371\/journal.ppat.1006993","volume":"14","author":"NS Baumann","year":"2018","unstructured":"Baumann NS, Torti N, Welten SPM, Barnstorf I, Borsa M, Pallmer K, Oduro JD, Cicin-Sain L, Ikuta K, Ludewig B, Oxenius A (2018) Tissue maintenance of CMV-specific inflationary memory T cells by IL-15. PLoS Pathog 14:e1006993","journal-title":"PLoS Pathog"},{"key":"597_CR99","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00430-015-0400-7","volume":"204","author":"E Ostermann","year":"2015","unstructured":"Ostermann E, Pawletko K, Indenbirken D, Schumacher U, Brune W (2015) Stepwise adaptation of murine cytomegalovirus to cells of a foreign host for identification of host range determinants. Med Microbiol Immunol 204:461\u2013469","journal-title":"Med Microbiol Immunol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00597-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-019-00597-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00597-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:36:08Z","timestamp":1744176968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-019-00597-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":99,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2019,8,1]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s00430-019-00597-7","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"31 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}